Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Booster COVID-19 vaccination against the SARS-CoV-2 Omicron variant: A systematic review
Yuxuan Du, Long Chen, Yuan Shi
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 25

Showing 25 citing articles:

Effectiveness of the pre-Omicron COVID-19 vaccines against Omicron in reducing infection, hospitalization, severity, and mortality compared to Delta and other variants: A systematic review
Pradipta Paul, Ahmed El-Naas, Omar Hamad, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 34
Comparison of the Effectiveness and Safety of Heterologous Booster Doses with Homologous Booster Doses for SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis
Jie Deng, Yirui Ma, Qiao Liu, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 17, pp. 10752-10752
Open Access | Times Cited: 35
Predictors of Willingness of the General Public to Receive a Second COVID-19 Booster Dose or a New COVID-19 Vaccine: A Cross-Sectional Study in Greece
Petros Galanis, Irène Vraka, Aglaia Katsiroumpa, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1061-1061
Open Access | Times Cited: 26
Individuals With Weaker Antibody Responses After Booster Immunization Are Prone to Omicron Breakthrough Infections
Birte Möhlendick, Ieva Čiučiulkaitė, Carina Elsner, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25
Effectiveness of full (booster) COVID-19 vaccination against severe outcomes and work absenteeism in hospitalized patients with COVID-19 during the Delta and Omicron waves in Greece
Helena C. Maltezou, Dimitrios Basoulis, Konstantinos Bonelis, et al.
Vaccine (2023) Vol. 41, Iss. 14, pp. 2343-2348
Open Access | Times Cited: 11
COVID-19-Related Burnout and Intention of Fully Vaccinated Individuals to Get a Booster Dose: The Mediating Role of Resilience
Petros Galanis, Aglaia Katsiroumpa, Panayota Sourtzi, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 62-62
Open Access | Times Cited: 14
Acceptance of COVID-19 Vaccines among Adults in Lilongwe, Malawi: A Cross-Sectional Study Based on the Health Belief Model
Qun Ao, Robert Okia Egolet, Hui Yin, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 760-760
Open Access | Times Cited: 13
Estimated Effectiveness of Prior SARS-CoV-2 BA.1 or BA.2 Infection and Booster Vaccination Against Omicron BA.5 Subvariant Infection
Eun Jung Jang, Young June Choe, Ryu Kyung Kim, et al.
JAMA Network Open (2023) Vol. 6, Iss. 3, pp. e232578-e232578
Open Access | Times Cited: 7
COVID-19 Disease in Under-5 Children: Current Status and Strategies for Prevention including Vaccination
Anish Pillai, Anuja Nayak, Deepika Tiwari, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 693-693
Open Access | Times Cited: 7
Recapping the Features of SARS-CoV-2 and Its Main Variants: Status and Future Paths
Miguel Á. Ortega, Cielo García‐Montero, Oscar Fraile‐Martínez, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 6, pp. 995-995
Open Access | Times Cited: 11
A DNA Vaccine Encoding the Full-Length Spike Protein of Beta Variant (B.1.351) Elicited Broader Cross-Reactive Immune Responses against Other SARS-CoV-2 Variants
Gan Zhao, Zhiyu Zhang, Yuan Ding, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 513-513
Open Access | Times Cited: 5
Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trial
Nawal Al Kaabi, Yun Yang, Yu Liang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 4
Humoral responses after primary and booster SARS‐CoV‐2 inactivated vaccination in patients with chronic hepatitis B virus infection: A longitudinal observational study
Zhiwei Chen, Tianquan Huang, Taiyu He, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Closed Access | Times Cited: 4
Differences in non-positive intention to accept the COVID-19 booster vaccine between three countries in the cross-border region Meuse-Rhine Euroregion: The Netherlands, Belgium, and Germany
Céline J.A. van Bilsen, Christina Stabourlos, Chrissy P. B. Moonen, et al.
Vaccine X (2023) Vol. 14, pp. 100306-100306
Open Access | Times Cited: 3
COVID-19 mRNA vaccine immunogenicity decay and breakthrough illness in adolescents and young adults with childhood-onset rheumatic diseases
Joo Guan Yeo, Kai Liang Teh, Wan Ni Chia, et al.
Lara D. Veeken (2023) Vol. 62, Iss. 9, pp. 3101-3109
Open Access | Times Cited: 2
An Overview of Signs and Symptoms to Determine Coronavirus and Omicron Patients in Primary Care and Hospitals
Ali M. Hussein, Hawry A. Majeed, Naz R. Majeed, et al.
Cihan University-Erbil Scientific Journal (2024) Vol. 8, Iss. 1, pp. 8-17
Open Access
The Scabbard of Excalibur: An Allegory on the Role of an Efficient and Effective Healthcare System under Universal Health Coverage during the Pandemic Response
Hiroyuki Noda
Healthcare (2024) Vol. 12, Iss. 10, pp. 979-979
Open Access
Protection conferred by booster vaccine doses in hospitalized patients with COVID-19 during the SARS-CoV-2 Omicron BA.2 and BA.5 epidemics from 2022–2023 in Greece
Helena C. Maltezou, Maria N. Gamaletsou, Maria Chini, et al.
Infectious Medicine (2024) Vol. 3, Iss. 4, pp. 100144-100144
Open Access
Navigating Vaccine Uncertainty: Anxiety and Fourth Dose Hesitancy Among Saudi Adults
Majed M Althomali, Anas S Almalki, Saad M. Alotaibi, et al.
Cureus (2023)
Open Access | Times Cited: 1
Evaluation of the Efficacy of COVID-19 Booster Vaccinations in Healthcare Personnel
Chung-Jong Kim, Ji Yun Bae, Kang-Il Jun, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1797-1797
Open Access | Times Cited: 2
Case Report: The Experience of Managing a Moderate ARDS Caused by SARS-CoV-2 Omicron BA.2 Variant in Chongqing, China: Can We Do Better?
Junnan Peng, Qiaoli Li, Jing Dong, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 1
Safety and immunogenicity of a broad-spectrum mosaic vaccine as a booster dose against SARS-CoV-2 Omicron and other circulating variants
Nawal Al Kaabi, Yun Yang, Yu Liang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Comparative Immunogenicity, Safety and Efficacy Profiles of four COVID-19 Vaccine types in healthy adults: Systematic Review cum Meta-analysis of Clinical Trial data
Si Qi Yoong, Priyanka Bhowmik, Debprasad Dutta
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Insights into Viral Zoonotic Diseases: COVID-19 and Monkeypox
A.K. Sachdev, Vengadesh Letchumanan
Progress In Microbes & Molecular Biology (2023) Vol. 6, Iss. 1
Open Access
COVID-19 omicron variant: variation from other variants, immune response, and vaccination against this rapidly spreading pandemic
Yehia A.‐G. Mahmoud, Amira Hathout, Radwa Abdallnasser Amen, et al.
Reviews in Medical Microbiology (2023)
Closed Access
Page 1

Scroll to top